About Us
Our Mission
The Asian Fund for Cancer Research Limited (AFCR) is committed to funding cancer research, especially those cancers prevalent in Asian populations, and promoting global collaborations for high impact to save the lives of cancer patients.
ADVANCING CUTTING-EDGE CANCER RESEARCH
BUILDING AN INTERNATIONAL NETWORK
CREATING COLLABORATIVE PLATFORMS
We believe that research holds the key that may end cancer. That’s why at AFCR, we place the highest priority in advancing cutting-edge cancer research in all important fields that will lead to better preventative methods, advanced diagnostic tools, more effective treatment approaches. We fund projects in a variety of important research fields, such as overcoming cancer’s resistance to chemotherapy, developing new screening tests for early detection, optimizing approaches of personalized medicine, and stopping cancer metastasis, etc.
AFCR provides the public with a wide variety of in-depth, user-friendly cancer prevention information and healthy lifestyle suggestions. We help the community understand the latest scientific achievements and their potential significance to improve the prevention, diagnosis and treatment of cancer. Armed with this knowledge, people can better protect themselves against cancer.
The State of Cancer Research
Support Us
We are making great progress against cancer, but there is still more to be done. And you can help.
Reports
![](https://afcr.org/wp-content/uploads/2024/06/chart-6765401_1280-1170x658.jpg)
2023 AFCR Impact Report
The Asian Fund for Cancer Research Limited (AFCR) is committed to fighting cancer through research into the prevention, diagnosis, and treatment of cancer. AFCR is dedicated to achieving one of medicine’s greatest goals: curing cancer to save lives. We fulfill this mission by funding outstanding scientists across Asia who pioneer cancer research.
![](https://afcr.org/wp-content/uploads/2024/07/coffee-8921522_1280-1170x658.jpg)
2022 BIOHK Think Tank Forum Report
The closed-door Think-Tank Dialogue, A Path Forward in Hong Kong for Cancer Eradication, organized by AFCR on December 15, 2022, as part of the BIOHK2022 conference, offers deep insights into the gaps and opportunities in cancer research and biotech innovation in Hong Kong. Delve into the AFCR Think-Tank Forum Report to learn more about Hong Kong's biomedical landscape.